FDA nod for chemo nausea and vomiting drug
US regulators have approved a new, long-acting treatment to stave off acute and delayed chemotherapy-related nausea and vomiting.
Read More
Tag: CINV
- Fabentech secures French approval for Ricimed antidote
- Oxford Drug Design reports major in vivo milestone for novel cancer therapy
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
